Vincerx Pharma (OTC:VINC) Stock, Quote.Headers.trade-ideas

Vincerx Pharma

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

Wall Street

Equities

News

Economics

Federal Reserve

Pre-Market Outlook

Markets

Analyst Ratings

AIEV

HIVE

LITM

NFLX

NVDA

SHF Holdings, Inc. - Class A Common Stock

SHFS

VINC

U.S. stock futures declined on Monday after a holiday-shortened week that ended with a mixed close on Thursday.

US Stocks Likely To Open Lower: &#39;Best And Worst Days Tend To Occur Near The Same Time,&#39; Says Expert

Crude Oil

Earnings

Eurozone

Commodities

Intraday Update

Trading Ideas

NEOG

PHIO

SMPL

VERO

XXII

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Nasdaq index

FMTO

SUNE

Nasdaq Gains Over 100 Points; Delta Air Lines Posts Upbeat Earnings

VINCERX PHARMA INC by Vincerx Pharma, Inc.

Vincerx Pharma Inc

VINchain

Vince Holding Corp

Vinci Partners Investments Ltd. - Class A Common Shares

Vinci Partners Investments Ltd

Vinci SA

VINCO VENTURES INC by Vinco Ventures, Inc.

Vinco Ventures Inc

Press Releases

VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders

Legal

Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders

Vincerx Pharma, Inc. Announces Reverse Stock Split

Health Care

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory's TROP2 Antibody Drug Conjugate, OQY-3258

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC

Comments

Vincerx Pharma

Vincerx Pharma (OTC:VINC) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell